Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04865250
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2021-03-08
Brief Title:
Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus CarboplatinNab Paclitaxel in Resectable Non-squamous NSCLC
Sponsor:
University Hospital Heidelberg
Organization:
University Hospital Heidelberg
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-08
First Submit QC Date:
April 25 2021
Study First Post Date:
2021-04-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-13
Last Update Post Date:
2024-05-16
Last Update Post Date Type:
ACTUAL